[
  {
    "ts": null,
    "headline": "UBS Downplays G7 CGM Sensor Concerns, Affirms DexCom’s Inc. (DXCM) ‘Buy’ Rating",
    "summary": "DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated the bullish stance even as the company faces concerns over its G7 continuous glucose monitoring sensor. The device has come […]",
    "url": "https://finnhub.io/api/news?id=8cbe684c75b555c4c53f335b3b32ad513cff795be754b8fac09aa6def66959e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759121810,
      "headline": "UBS Downplays G7 CGM Sensor Concerns, Affirms DexCom’s Inc. (DXCM) ‘Buy’ Rating",
      "id": 136913887,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated the bullish stance even as the company faces concerns over its G7 continuous glucose monitoring sensor. The device has come […]",
      "url": "https://finnhub.io/api/news?id=8cbe684c75b555c4c53f335b3b32ad513cff795be754b8fac09aa6def66959e0"
    }
  }
]